Retraction notice to "Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ROCK2 axis" [Biomed. Pharmacother. 125 (2020) 109882]
- PMID: 35835667
- DOI: 10.1016/j.biopha.2022.113356
Retraction notice to "Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ROCK2 axis" [Biomed. Pharmacother. 125 (2020) 109882]
Retraction of
-
RETRACTED: Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ROCK2 axis.Biomed Pharmacother. 2020 May;125:109882. doi: 10.1016/j.biopha.2020.109882. Epub 2020 Jan 29. Biomed Pharmacother. 2020. Retraction in: Biomed Pharmacother. 2022 Sep;153:113356. doi: 10.1016/j.biopha.2022.113356. PMID: 32006899 Retracted.
Similar articles
-
LncRNA TTN-AS1 acts as sponge for miR-15b-5p to regulate FBXW7 expression in ovarian cancer.Biofactors. 2020 Jul;46(4):600-607. doi: 10.1002/biof.1622. Epub 2020 Feb 12. Biofactors. 2020. PMID: 32049388
-
LncRNA TTN-AS1 Promotes Progression of Non-Small Cell Lung Cancer via Regulating miR-491-5p/ZNF503 Axis.Onco Targets Ther. 2020 Jul 1;13:6361-6371. doi: 10.2147/OTT.S238890. eCollection 2020. Onco Targets Ther. 2020. PMID: 32669856 Free PMC article.
-
Retraction notice to "Long noncoding RNA HOXD-AS1 promotes non-small cell lung cancer migration and invasion through regulating miR-133b/MMP9 axis" [Biomed. Pharmacother. 106 (2018) 156-162].Biomed Pharmacother. 2023 Dec 31;169:115376. doi: 10.1016/j.biopha.2023.115376. Epub 2023 Nov 27. Biomed Pharmacother. 2023. PMID: 38016887 No abstract available.
-
Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.Bioengineered. 2021 Dec;12(1):578-588. doi: 10.1080/21655979.2021.1882133. Bioengineered. 2021. PMID: 33517826 Free PMC article.
-
Long non-coding RNA TTN-AS1 promotes cell proliferation and inhibits cell apoptosis in prostatic cancer by sponging miR-193a-5p.Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7816-7825. doi: 10.26355/eurrev_201909_18991. Eur Rev Med Pharmacol Sci. 2019. PMID: 31599406
Publication types
LinkOut - more resources
Full Text Sources